Evaluation of Work Disability in Japanese Patients with Rheumatoid Arthritis: from the TOMORROW Study
Overview
Overview
Journal
Clin Rheumatol
Publisher
Springer
Specialty
Rheumatology
Date
2018 Mar 12
PMID
29525846
Citations
2
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Trial Registration: University Hospital Medical Information Network Clinical Trials Registry: UMIN000003876 . Registered 1 Jun 2010.
Citing Articles
Employment of patients with rheumatoid arthritis - a systematic review and meta-analysis.
Kirkeskov L, Bray K BMC Rheumatol. 2023; 7(1):41.
PMID: 37964371 PMC: 10644429. DOI: 10.1186/s41927-023-00365-4.
Salari N, Kazeminia M, Shohaimi S, Mohammadi M Clin Rheumatol. 2021; 40(11):4511-4525.
PMID: 34159490 DOI: 10.1007/s10067-021-05829-x.
References
1.
Smolen J, Breedveld F, Burmester G, Bykerk V, Dougados M, Emery P
. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis. 2015; 75(1):3-15.
PMC: 4717393.
DOI: 10.1136/annrheumdis-2015-207524.
View
2.
Puolakka K, Kautiainen H, Mottonen T, Hannonen P, Korpela M, Julkunen H
. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial. Arthritis Rheum. 2004; 50(1):55-62.
DOI: 10.1002/art.11436.
View
3.
Rantalaiho V, Kautiainen H, Korpela M, Hannonen P, Kaipiainen-Seppanen O, Mottonen T
. Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial,.... Ann Rheum Dis. 2013; 73(11):1954-61.
DOI: 10.1136/annrheumdis-2013-203497.
View
4.
Allaire S, Wolfe F, Niu J, Zhang Y, Zhang B, LaValley M
. Evaluation of the effect of anti-tumor necrosis factor agent use on rheumatoid arthritis work disability: the jury is still out. Arthritis Rheum. 2008; 59(8):1082-9.
PMC: 3653626.
DOI: 10.1002/art.23923.
View
5.
Puolakka K, Kautiainen H, Mottonen T, Hannonen P, Korpela M, Hakala M
. Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial. Arthritis Rheum. 2005; 52(1):36-41.
DOI: 10.1002/art.20716.
View